BridgeMD
Prevention study for Acute Kidney Injury
Official title Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery
ClinicalTrials.gov ID: NCT06972082
What this study is testing
- What it's testing
- The main goal of this clinical trial is to learn if evaluation by ultrasound of venous congestion of liver and kidneys can guide treatment and prevent and treat acute kidney injury post cardiac surgery (CSA-AKI). Participants will: Be evaluated by liver and kidney veins ultrasound (treatment group) or a placebo post CSA-AKI.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients in the Cardiac Surgery ICU who develop acute kidney injury according to KDIGO criteria, within 48 hours of ICU admission after cardiac...
- Elective and non-elective cardiac surgery.
You likely can't join if
- Patient refusal
- Severe chronic renal failure (GFR\<15 mL/min/m2 or on hemodialysis).
- Critical preoperative condition (severe cardiogenic shock, resuscitated cardiac arrest, support with mechanical circulatory assist devices).
- Liver cirrhosis or inferior vena cava obstruction.
- Pregnancy.
- Morbid obesity (BMI\>40 kg/m2).
See the full eligibility criteria
- Patients in the Cardiac Surgery ICU who develop acute kidney injury according to KDIGO criteria, within 48 hours of ICU admission after cardiac surgery
- Elective and non-elective cardiac surgery.
- Patient refusal
- Severe chronic renal failure (GFR\<15 mL/min/m2 or on hemodialysis).
- Critical preoperative condition (severe cardiogenic shock, resuscitated cardiac arrest, support with mechanical circulatory assist devices).
- Liver cirrhosis or inferior vena cava obstruction.
- Pregnancy.
- Morbid obesity (BMI\>40 kg/m2).
- Delirium or other condition that prevents the performance of an ultrasound study.
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Kallithea, Greece
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Kallithea, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.